Ryman Healthcare (RYM): FY20 — Initial Thoughts
Ryman Healthcare (RYM) FY20 — Initial thoughts Result in-line – business well on track RYM FY20 underlying profit was NZ$242m, up +7% versus our...
73 Views
Ryman Healthcare: FY20 Result Preview
Ryman Healthcare FY20 Result Preview OUTPERFORM Ryman Healthcare (RYM) will report its FY20 result on 12 June and we are forecasting steady EPS...
116 Views
Hygeia Healthcare IPO: Valuation Insights
Hygeia Healthcare Group (1702613D CH) is the largest oncology healthcare group in China as measured by the revenue generated from...
382 Views
Smartkarma Webinar | High-Conviction Ideas in Asian Infrastructure Stocks
In the next Smartkarma Webinar, we will be joined by Buyside Portfolio Manager Susanta Mazumdar who will discuss 5 key themes and 7 high-conviction...
499 Views
Ryman Healthcare: Upgrade to OUTPERFORM
Ryman Healthcare Upgrade to OUTPERFORM OUTPERFORM The recent significant pull back in the RYM share price is an opportunity to buy the market...
324 Views